BEIGENE, LTD. |
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 162.5 USD | +3.79% |
|
+9.71% | -9.63% |
| Apr. 23 | Sector Update: Health Care Stocks Rise in Afternoon Trading | MT |
| Apr. 23 | BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer; Shares Rise | MT |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-04-26 | 2024-04-29 | 2024-04-30 | 2024-05-01 | 2024-05-02 | |
|---|---|---|---|---|---|
| Last | 153.58 $ | 156.53 $ | 153.94 $ | 156.53 $ | 162.7 $ |
| Volume | 208 460 | 185 728 | 205 282 | 176 901 | 145 107 |
| Change | +3.38% | +1.92% | -1.65% | +1.68% | +3.79% |
| Opening | 152.11 | 155.00 | 155.00 | 154.30 | 161 |
| High | 154.47 | 157.89 | 156.64 | 157.89 | 164.6 |
| Low | 150.73 | 153.08 | 150.29 | 154.30 | 158.8 |
Performance
| 1 day | +1.68% | ||
| 1 week | +8.61% | ||
| Current month | +1.68% | ||
| 1 month | -1.70% | ||
| 3 months | +4.40% | ||
| 6 months | -13.66% | ||
| Current year | -13.21% | ||
| 1 year | -39.79% | ||
| 3 years | -54.44% | ||
| 5 years | +24.04% |
Volumes
marketsDaily volume
176 901
Estimated daily volume
176 901
Avg. Volume 20 sessions
226 386
Daily volume ratio
0.78
Avg. Volume 20 sessions USD
35 436 200.58
Record volume 1
5 213 382
Record volume 2
4 495 595
Record volume 3
3 090 941
Capital turnover ratio
0.00
Float rotation
0.00
Basic data
Capitalization (USD)
16 360 198 939
Net sales (USD)
2 458 779 000
Number of employees
10 600
Sales / Employee (USD)
231 960
Free-Float
98.21 %
Free-Float capitalization (USD)
191 367 724 595
Average Daily Capital Traded
0.22%
Highs and lows
1 week
150.29
157.89
1 month
126.97157.89
Current year
126.97184.80
1 year
126.97266.67
3 years
118.18426.56
5 years
113.01426.56
10 years
22.51426.56
Indicators
Moving average 5 days
153.83
Moving average 20 days
144.25
Moving average 50 days
154.96
Moving average 100 days
160.50
Price spread / (MMA5)
-1.73%
Price spread / (MMA20)
-7.84%
Price spread / (MMA50)
-1.00%
Price spread / (MMA100)
+2.54%
STIM
RSI 9 days
63.24
RSI 14 days
56.44
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +1.68% | +8.61% | -13.21% | -39.79% | 16.36B | ||
| +2.38% | +0.34% | -1.17% | +16.56% | 104B | ||
| +1.44% | -0.34% | +2.87% | +11.99% | 97.47B | ||
| +1.91% | +2.38% | +4.08% | -0.78% | 22.25B | ||
| +1.27% | +2.11% | -14.77% | -19.68% | 21.68B | ||
| -0.19% | -2.12% | -8.79% | -29.65% | 18.2B | ||
| -2.02% | +3.73% | -39.98% | -35.33% | 17.02B | ||
| +3.99% | +2.92% | +8.55% | +37.50% | 14.39B | ||
| +3.35% | +5.35% | +35.75% | +4.63% | 12.37B | ||
| -4.01% | +17.40% | +310.48% | +245.34% | 8.43B | ||
| +0.55% | -2.63% | -26.91% | -34.59% | 8B | ||
| +1.86% | -1.52% | +11.96% | +62.57% | 8.06B | ||
| -0.22% | +1.71% | +0.51% | +36.15% | 7.74B | ||
| +5.97% | +12.17% | -50.81% | -68.69% | 7.31B | ||
| -6.54% | -7.53% | -8.61% | +16.44% | 6.39B | ||
| +5.22% | +5.66% | +1.45% | +32.01% | 6.93B | ||
| Average | +1.04% | +2.63% | +13.21% | +14.67% | ||
| Weighted average by Cap. | +1.51% | +1.41% | +4.04% | +9.70% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
df27af1a0b46fed3442849c5fdc6.O4TQj2eO7jrynYL0BGOBxGPrOfRYUo1kikn5PKX9Tdo.ZLyI6ybcqg-2sOPHNwi5sCeNWLgVGMgR-Ry-EfSzI7NVx5rQKu-sY7zvxw
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 04:00:00 pm | 156.5 | 16,441 | 113,868 |
| 03:59:54 pm | 156.5 | 100 | 97,427 |
| 03:59:53 pm | 156.5 | 100 | 97,327 |
| 03:59:52 pm | 156.5 | 134 | 97,227 |
| 03:59:52 pm | 156.5 | 266 | 97,093 |
| 03:59:52 pm | 156.5 | 100 | 96,827 |
| 03:59:52 pm | 156.5 | 100 | 96,727 |
| 03:59:52 pm | 156.5 | 100 | 96,627 |
| 03:59:52 pm | 156.5 | 100 | 96,527 |
| 03:59:50 pm | 156.5 | 100 | 96,427 |
Monthly variations
Annual change
| 2024 | -13.21% | ||
| 2023 | -18.00% | ||
| 2022 | -18.82% | ||
| 2021 | +4.85% | ||
| 2020 | +55.88% | ||
| 2019 | +18.18% | ||
| 2018 | +43.53% | ||
| 2017 | +221.87% | ||
| 2016 | +7.20% |
- Stock Market
- Equities
- BGNE Stock
- Quotes BeiGene, Ltd.
